Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
palbociclib 75 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lidocaine hydrochloride monohydrate 2% (36 mg/1.8 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/1.8 mL) injection, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 22.5 g/1.97 L + medium chain triglycerides 22.5 g/1.97 L + olive oil 18.8 g/1.97 L + fish oil 11.3 g/1.97 L injection, 375 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
trifarotene 0.005% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glucose 250 g/1.97 L injection, 595 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
teriparatide 250 microgram/mL injection, 2.4 mL cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
bortezomib 2.5 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 14 g/1.97 L + arginine 12 g/1.97 L + glycine 11 g/1.97 L + histidine 3 g/1.97 L + isoleucine 5 g/1.97 L + leucine 7.4 g/1.97 L + lysine 6.6 g/1.97 L + methionine 4.3 g/1.97 L + phenylalanine 5.1 g/1.97 L + proline 11.2 g/1.97 L + serine 6.5 g/1.97 L + taurine 1 g/1.97 L + threonine 4.4 g/1.97 L + tryptophan 2 g/1.97 L + tyrosine 400 mg/1.97 L + valine 6.2 g/1.97 L injection, 1 L chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 7 g/986 mL + arginine 6 g/986 mL + glycine 5.5 g/986 mL + histidine 1.5 g/986 mL + isoleucine 2.5 g/986 mL + leucine 3.7 g/986 mL + lysine 3.3 g/986 mL + methionine 2.2 g/986 mL + phenylalanine 2.6 g/986 mL + proline 5.6 g/986 mL + serine 3.2 g/986 mL + taurine 500 mg/986 mL + threonine 2.2 g/986 mL + tryptophan 1 g/986 mL + tyrosine 200 mg/986 mL + valine 3.1 g/986 mL + calcium chloride 280 mg/986 mL + sodium glycerophosphate 2.1 g/986 mL + magnesium sulfate 600 mg/986 mL + potassium chloride 2.2 g (potassium 30 mmol)/986 mL + sodium acetate 1.7 g/986 mL + zinc sulfate 6.5 mg/986 mL injection, 500 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 11.3 g/986 mL + medium chain triglycerides 11.3 g/986 mL + olive oil 9.4 g/986 mL + fish oil 5.6 g/986 mL injection, 188 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glucose 125 g/986 mL injection, 298 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glucose 313 g/2.463 L injection, 744 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 17.5 g/2.463 L + arginine 15 g/2.463 L + glycine 13.8 g/2.463 L + histidine 3.7 g/2.463 L + isoleucine 6.2 g/2.463 L + leucine 9.4 g/2.463 L + lysine 8.4 g/2.463 L + methionine 5.4 g/2.463 L + phenylalanine 6.4 g/2.463 L + proline 14 g/2.463 L + serine 8.1 g/2.463 L + taurine 1.2 g/2.463 L + threonine 5.4 g/2.463 L + tryptophan 2.5 g/2.463 L + tyrosine 490 mg/2.463 L + valine 7.6 g/2.463 L + calcium chloride 690 mg/2.463 L + sodium glycerophosphate 5.2 g/2.463 L + magnesium sulfate 1.5 g/2.463 L + potassium chloride 5.7 g (potassium 74 mmol)/2.463 L + sodium acetate 4.2 g/2.463 L + zinc sulfate 16 mg/2.463 L injection, 1.25 L chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 28.1 g/2.463 L + medium chain triglycerides 28.1 g/2.463 L + olive oil 23.5 g/2.463 L + fish oil 14.1 g/2.463 L injection, 469 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
trientine dihydrochloride 250 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
COVID-19 ChAdOx1-S viral vector vaccine, 4 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glucose 187 g/1.477 L injection, 446 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 10.5 g/1.477 L + arginine 9 g/1.477 L + glycine 8.2 g/1.477 L + histidine 2.2 g/1.477 L + isoleucine 3.8 g/1.477 L + leucine 5.6 g/1.477 L + lysine 5 g/1.477 L + methionine 3.2 g/1.477 L + phenylalanine 3.8 g/1.477 L + proline 8.4 g/1.477 L + serine 4.9 g/1.477 L + taurine 750 mg/1.477 L + threonine 3.3 g/1.477 L + tryptophan 1.5 g/1.477 L + tyrosine 300 mg/1.477 L + valine 4.6 g/1.477 L + calcium chloride 420 mg/1.477 L + sodium glycerophosphate 3.1 g/1.477 L + magnesium sulfate 900 mg/1.477 L + potassium chloride 3.4 g (potassium 45 mmol)/1.477 L + sodium acetate 2.6 g/1.477 L + zinc sulfate 9.7 mg/1.477 L injection, 750 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 16.9 g/1.477 L + medium chain triglycerides 16.9 g/1.477 L + olive oil 14.1 g/1.477 L + fish oil 8.4 g/1.477 L injection, 281 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
diazepam 10 mg/10 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
esketamine 28 mg/2 actuations nasal spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent vaccine 2021 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent adjuvanted geriatric vaccine 2021 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent cell based vaccine 2021, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 68 microgram powder for inhalation, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pregabalin 165 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pregabalin 330 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pregabalin 82.5 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ciclosporin 0.1% eye drops, unit dose |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabotegravir 30 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ofatumumab 20 mg/0.4 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ofatumumab 20 mg/0.4 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ravulizumab 300 mg/3 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
onasemnogene abeparvovec 20 trillion vector genomes/mL injection, 8.3 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
onasemnogene abeparvovec 20 trillion vector genomes/mL injection, 5.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabotegravir 600 mg/3 mL modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
rilpivirine 600 mg/2 mL modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ravulizumab 1.1 g/11 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabotegravir 400 mg/2 mL modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
rilpivirine 900 mg/3 mL modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
perampanel 2 mg/4 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
crizanlizumab 100 mg/10 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
follitropin alfa 300 units (22 microgram)/0.5 mL injection, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
follitropin alfa 900 units (66 microgram)/1.5 mL injection, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
follitropin alfa 450 units (33 microgram)/0.75 mL injection, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
carmustine 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
calcium carbonate 1.249 g (calcium 500 mg) + colecalciferol 5 microgram (200 units) effervescent tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 17% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
noradrenaline (norepinephrine) 6 mg/50 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
noradrenaline (norepinephrine) 3 mg/50 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
buprenorphine 160 mg/0.45 mL modified release injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
hydrocortisone 500 microgram granules, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
hydrocortisone 2 mg granules, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
hydrocortisone 1 mg granules, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
hydrocortisone 5 mg granules, capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 250 mL carton |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
etanercept 50 mg/mL injection, cartridge |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 250 mL carton |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 18 g/2.025 L + medium chain triglycerides 18 g/2.025 L + olive oil 15 g/2.025 L + fish oil 8.8 g/2.025 L injection, 292 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glucose 171 g/2.025 L injection, 408 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 19 g/2.025 L + arginine 16 g/2.025 L + glycine 15 g/2.025 L + histidine 4 g/2.025 L + isoleucine 6.6 g/2.025 L + leucine 9.8 g/2.025 L + lysine 8.7 g/2.025 L + methionine 5.7 g/2.025 L + phenylalanine 6.8 g/2.025 L + proline 15 g/2.025 L + serine 8.6 g/2.025 L + taurine 1.3 g/2.025 L + threonine 5.8 g/2.025 L + tryptophan 2.7 g/2.025 L + tyrosine 530 mg/2.025 L + valine 8.2 g/2.025 L + calcium chloride 580 mg/2.025 L + sodium glycerophosphate 4.6 g/2.025 L + magnesium sulfate 1.2 g/2.025 L + potassium chloride 4.6 g (potassium 61.9 mmol)/2.025 L + sodium acetate 3.3 g/2.025 L + zinc sulfate 13 mg/2.025 L injection, 1.325 L chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 300 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 210 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 405 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as diaspartate) 300 microgram/mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as diaspartate) 900 microgram/mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as diaspartate) 600 microgram/mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as embonate) 20 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as embonate) 40 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pasireotide (as embonate) 60 mg modified release injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
paracetamol 120 mg/5 mL + codeine phosphate hemihydrate 5 mg/5 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing hydrogel 5 cm x 7.5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing with silver 5 cm x 5 cm tulle dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing hydrogel 12.5 cm x 12.5 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing with silver 10 cm x 20 cm tulle dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing hydrogel 7.5 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing non-adherent absorbent 20 cm x 40 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing non-adherent absorbent 10 cm x 20 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing non-adherent with silicone 5 cm x 7 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing non-adherent absorbent 10 cm x 10 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
eslicarbazepine acetate 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
eslicarbazepine acetate 800 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
trabectedin 250 microgram injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabazitaxel 45 mg/4.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
olopatadine 600 microgram/actuation + mometasone furoate 25 microgram/actuation nasal spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
eptinezumab 100 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
chlormethine 0.016% (160 microgram/g) gel |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
fremanezumab 225 mg/1.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
liquid paraffin + glycerol + tyloxapol + poloxamer-188 + trometamol hydrochloride + trometamol + cetalkonium chloride eye drops |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
risdiplam 750 microgram/mL powder for oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
trabectedin 1 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
somatropin 5.3 mg injection, chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lemborexant 10 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lemborexant 5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
alanine 19.13 g/1.82 L + arginine 10.63 g/1.82 L + glycine 9.52 g/1.82 L + histidine 4.44 g/1.82 L + isoleucine 5.54 g/1.82 L + leucine 6.75 g/1.82 L + lysine 5.36 g/1.82 L + methionine 3.7 g/1.82 L + phenylalanine 5.17 g/1.82 L + proline 6.28 g/1.82 L + serine 4.62 g/1.82 L + threonine 3.88 g/1.82 L + tryptophan 1.66 g/1.82 L + tyrosine 370 mg/1.82 L + valine 5.36 g/1.82 L + sodium acetate trihydrate 5.19 g/1.82 L + potassium chloride 4.14 g (potassium 55.5 mmol)/1.82 L + calcium chloride dihydrate 680 mg/1.82 L + magnesium sulfate heptahydrate 2.28 g/1.82 L + sodium glycerophosphate hydrate 5.47 g/1.82 L + zinc sulfate heptahydrate 21 mg/1.82 L injection, 924 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
noradrenaline (norepinephrine) 5 mg/50 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cannabidiol 100 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
fostemsavir 600 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 26 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|